Intravenous Iron in paTients With Heart failURe and Reduced Ejection fracTion (HFREF) pLus Iron dEficiency
Status:
Completed
Trial end date:
2017-10-25
Target enrollment:
Participant gender:
Summary
Effects of ferric carboxymaltose single HD (1000 mg) infusion upon FGF23 in patients with
isolated HFREF compared to patients with HFREF+CKD (all pts with iron deficiency). This study
aims at identification of the optimal target population for a follow-up ("main") study.